Polysaccharide-based materials in macromolecular prodrug design and development

References

• V. Llopis-Hernandez, M. Cantini, C. Gonzalez-Garc and M. Salmeron-Sanchez: ‘Material-based strategies to engineer fibronectin matrices for regenerative medicine’, Int. Mater. Rev., 2015, 60, 245–263.
   Web of Science ®Google Scholar
• C. Fischbach and D. J. Mooney: ‘Polymers for pro- and anti-angiogenic therapy’, Biomaterials, 2007, 28, 2069–2076.
   PubMed Web of Science ®Google Scholar
• R. Langer and D. A. Tirrell: ‘Designing materials for biology and medicine’, Nature, 2004, 428, 487–492.
   PubMed Web of Science ®Google Scholar
• M. P. Lutolf and J. A. Hubbell: ‘Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering’, Nat. Biotechnol., 2005, 23, 47–55.
   PubMed Web of Science ®Google Scholar
• J. Vinsova and E. Vavrikova: ‘Recent advances in drugs and prodrugs design of chitosan’, Curr. Pharm. Desig., 2008, 14, 1311–1326.
   PubMed Web of Science ®Google Scholar
• J. Folkman and D. M. Long: ‘The use of silicone rubber as a carrier for prolonged drug therapy’, J. Surg. Res., 1964, 4, 139–142.
   PubMed Web of Science ®Google Scholar
• H. Ringsdorf: ‘Structure and properties of pharmacologically active polymers’, J. Polym. Sci. Polym. Symp., 1975, 51, 135–153.
   Google Scholar
• K. L. Kiick: ‘Polymer therapeutics’, Science, 2007, 317, 1182–1183.
   PubMed Web of Science ®Google Scholar
• R. Duncan: ‘Polymer conjugates as anticancer nanomedicines’, Nat. Rev. Cancer, 2006, 6, 688–701.
   PubMed Web of Science ®Google Scholar
• N. S. Abbas, M. Amin, M. A. Hussain, K. J. Edgar, M. N. Tahir and W. Tremel: ‘Extended release and enhanced bioavailability of moxifloxacin conjugated with hydrophilic cellulose ethers’, Carbohydr. Polym., 2016, 136, 1297–1306.
   PubMed Web of Science ®Google Scholar
• M. A. Hussain, K. Abbas, M. Amin, B. A. Lodhi, S. Iqbal, M. N. Tahir and W. Tremel: ‘Novel high-loaded, nanoparticulate and thermally stable macromolecular prodrug design of NSAIDs based on hydroxypropylcellulose’, Cellulose, 2015, 22, (1), 461–471.
   Web of Science ®Google Scholar
• K. J. Watson, D. R. Anderson and S. T. Nguyen: ‘Toward polymeric anticancer drug cocktails from ring-opening metathesis polymerization’, Macromolecules, 2001, 34, 3507–3509.
   Web of Science ®Google Scholar
• M. Amin, N. S. Abbas, M. A. Hussain, K. Edgar, M. N. Tahir, W. Tremel and M. Sher: ‘Cellulose ether derivatives: a new platform for prodrug formation of fluoroquinolone antibiotics’, Cellulose, 2015, 22, (3), 2011–2022.
   Web of Science ®Google Scholar
• E. R. Gillies, A. P. Goodwin and J. M. J. Frechet: ‘Acetals as pH-sensitive linkages for drug delivery’, Bioconj. Chem., 2004, 15, 1254–1263.
   PubMed Web of Science ®Google Scholar
• Y. S. Kim, E. S. Gil and T. L. Lowe: ‘Synthesis and characterization of thermoresponsive-co-biodegradable linear-dendritic copolymers’, Macromolecules, 2006, 39, 7805–7811.
   Web of Science ®Google Scholar
• A. W. York, S. E. Kirkland and C. L. McCormick: ‘Advances in the synthesis of amphiphilic block copolymers via RAFT polymerization: stimuli-responsive drug and gene delivery’, Adv. Drug Deliv. Rev., 2008, 60, 1018–1036.
   PubMed Web of Science ®Google Scholar
• S. Liu, R. Maheshwari and K. L. Kiick: ‘Polymer-based therapeutics’, Macromolecules, 2009, 42, 3–13.
   PubMed Web of Science ®Google Scholar
• O. Germershaus, T. Luhmann, J.-C. Rybak, J. Ritzer and L. Meinel: ‘Application of natural and semi-synthetic polymers for the delivery of sensitive drugs’, Int. Mater. Rev., 2015, 60, 101–130.
   Web of Science ®Google Scholar
• A. Rosler, G. W. M. Vandermeulen and H. A. Klok: ‘Advanced drug delivery devices via self-assembly of amphiphilic block copolymers’, Adv. Drug Deliv. Rev., 2001, 53, 95–108.
   PubMed Web of Science ®Google Scholar
• I. Brigger, C. Dubernet and P. Couvreur: ‘Nanoparticles in cancer therapy and diagnosis’, Adv. Drug Deliv. Rev., 2002, 54, 631–651.
   PubMed Web of Science ®Google Scholar
• K. Hoste, K. De Winne and E. Schacht: ‘Polymeric prodrugs’, Int. J. Pharm., 2004, 277, 119–131.
   PubMed Web of Science ®Google Scholar
• W. Amass, A. Amass and B. Tighe: ‘A review of biodegradable polymers: uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies’, Polym. Int., 1998, 47, 89–144.
   Web of Science ®Google Scholar
• P. T. Anastas and J. C. Warner: ‘Green chemistry: theory and practice’, 1998, New York, Oxford University Press.
   Google Scholar
• P. Tundo, P. Anastas, D. S. Black, J. Breen, T. Collins, S. Memoli, J. Miyamoto, M. Polyakoff and W. Tumas: ‘Synthetic pathways and processes in green chemistry: introductory overview’, Pure Appl. Chem., 2000, 72, 1207–1228.
   Web of Science ®Google Scholar
• D. L. Kaplan, Ed., ‘Biopolymers from renewable resources: macromolecular systems-materials approach’, 1998, Berlin, Heidelberg, New York, Springer.
   Google Scholar
• E. Chiellini and R. Solaro, Eds., ‘Recent advances in biodegradable polymers and plastics’, 2003, Weinheim, Wiley-VCH.
   Google Scholar
• M. E. Gomes and R. L. Reis: ‘Biodegradable polymers and composites in biomedical applications: from catgut to tissue engineering. Part 1 available systems and their properties’, Int. Mater. Rev., 2004, 49, 261–273.
   Web of Science ®Google Scholar
• J. Puls, C. Altaner and B. Saake: ‘Cellulose acetates: properties and applications’, (ed. P. Rustemeyer), 2004, Weinheim, Wiley-VCH.
   Google Scholar
• E. Samios, R. K. Dart and J. V. Dawkins: ‘Preparation, characterization and biodegradation studies on cellulose acetates with varying degrees of substitution’, Polymer, 1997, 38, (12), 3045–3054.
   Web of Science ®Google Scholar
• A. Abbas, M. A. Hussain, M. Amin, M. N. Tahir, I. Jantan, A. Hameed and S. N. A. Bukhari: ‘Multiple cross-linked hydroxypropylcellulose-succinate-salicylate: Prodrug design, characterization, stimuli responsive swelling-deswelling and sustained drug release’, RSC Adv., 2015, 5, 43440–43448.
   Web of Science ®Google Scholar
• L. Y. Qiu and Y. H. Bae: ‘Polymer architecture and drug delivery’, Pharm. Res., 2006, 23, 1–30.
   PubMed Web of Science ®Google Scholar
• P. J. Marsac and L. S. Taylor: ‘Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters’, Pharm. Res., 2009, 26, 139–151.
   PubMed Web of Science ®Google Scholar
• K. A. Elkhodairy, N. S. Barakat and F. K. Alanazi: ‘Solubilization and amorphization of non-steroidal anti-inflammatory drug with low molecular weight chitosan for a new guar-based colon delivery formulation’, Lett. Drug Des. Discov., 2011, 8, 292–301.
   Web of Science ®Google Scholar
• S. K. Jain, A. Jain, Y. Gupta and M. Ahirwar: ‘Design and development of hydrogel beads for targeted drug delivery to the colon’, AAPS PharmSciTech., 2007, 8, 34–41.
   Web of Science ®Google Scholar
• T. Nishikawa, K. Akiyoshi and J. Sunamoto: ‘Macromolecular complexation between bovine serum albumin and the self-assembled hydrogel nanoparticle of hydrophobized polysaccharides’, J. Am. Chem. Soc., 1996, 118, 6110–6115.
   Web of Science ®Google Scholar
• J. A. Hubbell: ‘Materials science: enhancing drug function’, Science, 2003, 300, 595–596.
   PubMed Web of Science ®Google Scholar
• K. Na, T. B. Lee, K. H. Park, E. K. Shin, Y. B. Lee and H. K. Choi: ‘Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system’, Eur. J. Pharm. Sci., 2003, 18, 165–173.
   PubMed Web of Science ®Google Scholar
• L. Liu, P. Jin, M. Cheng, G. Zhang and F. Zhang: ‘5-Fluorouracil-loaded self-assembled pH-sensitive nanoparticles as novel drug carrier for treatment of malignant tumors’, Chin. J. Chem. Eng., 2006, 14, 377–382.
   Web of Science ®Google Scholar
• R. Duncan: ‘The dawning era of polymer therapeutics’, Nat. Rev. Drug Discov., 2003, 2, 347–360.
   PubMed Web of Science ®Google Scholar
• D. A. Wood: ‘Biodegradable drug delivery systems’, Int. J. Pharm., 1980, 7, 1–18.
   Web of Science ®Google Scholar
• J. Khandare and T. Minko: ‘Polymer-drug conjugates: progress in polymeric prodrugs’, Prog. Polym. Sci., 2006, 31, 359–397.
   Web of Science ®Google Scholar
• M. J. Hawkins, P. S. Shiong and N. Desai: ‘Protein nanoparticles as drug carriers in clinical medicine’, Adv. Drug Deliv. Rev., 2008, 60, 876–885.
   PubMed Web of Science ®Google Scholar
• V. P. Torchilin and A. N. Lukyanov: ‘Peptide and protein drug delivery to and into tumors: challenges and solutions’, Drug Discov. Today, 2003, 8, 259–266.
   PubMed Web of Science ®Google Scholar
• A. Trouet and D. D. Campeneere: ‘Daunorubicin-DNA and doxorubicin-DNA a review of experimental and clinical data’, Cancer Chemother. Pharmacol., 1979, 2, 77–79.
   PubMed Web of Science ®Google Scholar
• X. Cheng, F. Zhang, G. Zhou, S. Gao, L. Dong, W. Jiang, Z. Ding, J. Chen and J. Zhang: ‘DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin’, Drug Deliv., 2009, 16, 135–144.
   PubMed Web of Science ®Google Scholar
• D. Klemm, B. Phillip, T. Heinze and U. Heinze: ‘Comprehensive cellulose chemistry’, (ed. W. Wagenknecht), 1998, Weinheim, Wiley-VCH.
   Google Scholar
• M. A. Hussain: ‘Unconventional synthesis and characterization of novel abietic acid esters of hydroxypropylcellulose as potential macromolecular prodrugs’, J. Polym. Sci. A: Pol. Chem., 2008, 46, 747–752.
   Web of Science ®Google Scholar
• M. A. Hussain and T. Heinze: ‘Unconventional synthesis of pullulan abietates’, Polym. Bull., 2008, 60, 775–783.
   Web of Science ®Google Scholar
• C. Larsen: ‘Macromolecular prodrugs. XII. Kinetics of release of naproxen from various polysaccharide ester prodrugs in neutral and alkaline solution’, Int. J. Pharm., 1989, 51, 233–240.
   Web of Science ®Google Scholar
• C. Y. Won and C. C. Chu: ‘Dextran-estrone conjugate: synthesis and in vitro release study’, Carbohydr. Polym., 1988, 36, 327–334.
   Web of Science ®Google Scholar
• S. Y. Zhou, Q. B. Mei, L. Liu, B. L. Zhang, C. Li and J. Zhou: ‘Characteristics of drug-release in vitro of different dextran-dexamethasone conjugates’, Yao Xue Xue Bao, 2003, 38, 388–391.
   PubMedGoogle Scholar
• H. Nogusa, K. Yamamoto, T. Yano, M. Kajiki, H. Hamana and S. Okuno: ‘Distribution characteristics of carboxymethylpullulan-peptide-doxorubicin conjugates in tumor-bearing rats: different sequence of peptide spacers and doxorubicin contents’, Biol. Pharm. Bull., 2000, 23, 621–626.
   PubMed Web of Science ®Google Scholar
• S. G. Lévesque and M. S. Shoichet: ‘Synthesis of enzyme-degradable, peptide-cross-linked dextran hydrogels’, Bioconj. Chem., 2007, 18, 874–885.
   PubMed Web of Science ®Google Scholar
• E. Roseeuw, V. Coessens, A. M. Balazuc, M. Lagranderie, P. Chavarot, A. Pessina, M. G. Neri, E. Schacht, G. Marchal and D. Domurado: ‘Synthesis, degradation, and antimicrobial properties of targeted macromolecular prodrugs of norfloxacin’, Antimicrob. Agents Chemother., 2003, 47, 3435–3441.
   PubMed Web of Science ®Google Scholar
• J. A. Guu, G. H. Hsiue and T. M. Juang: ‘Synthesis and biological properties of antitumor-active conjugates of ADR with dextran’, J. Biomater. Sci. Polym. Ed., 2002, 13, 1135–1151.
   PubMed Web of Science ®Google Scholar
• C. Y. Won, C. C. Chu and T. J. Yu: ‘Synthesis of starch-based drug carrier for the control release of estrone hormone’, Carbohyd. Polym., 1997, 32, 239–244.
   Web of Science ®Google Scholar
• M. R. Rekha and C. P. Sharma: ‘Hemocompatible pullulan-polyethyleneimine conjugates for liver cell gene delivery: ‘in vitro evaluation of cellular uptake, intracellular trafficking and transfection efficiency’, Acta Biomater., 2011, 7, 370–379.
   PubMed Web of Science ®Google Scholar
• A. D. McLeod, D. R. Friend and T. N. Tozer: ‘Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents’, J. Pharm. Sci., 1994, 83, 1284–1288.
   PubMed Web of Science ®Google Scholar
• J. Varshosaz, J. Emami, F. Ahmadi, N. Tavakoli, M. Minaiyan, A. Fassihi, P. Mahzouni and F. Dorkooosh: ‘Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis’, J. Drug. Target., 2011, 19, 140–153.
   PubMed Web of Science ®Google Scholar
• C. Mura, D. Valenti, R. Sanna, M. A. De Luca, A. M. Fadda and G. Loy: ‘Metronidazole prodrugs: synthesis, physicochemical properties, stability, and ex vivo release studies’, Eur. J. Med. Chem., 2011, 46, 4142–4150.
   PubMed Web of Science ®Google Scholar
• K. Na and Y. H. Bae: ‘Self-assembled hydrogel nanoparticles responsive to tumor extracellular pH from pullulan derivative/sulfonamide conjugate: characterization, aggregation, and adriamycin release in vitro’, Pharm. Res., 2002, 19, 681–688.
   PubMed Web of Science ®Google Scholar
• P. K. Shrivastava and S. K. Shrivastava: ‘Dextran carrier macromolecule for colon specific delivery of celecoxib’, Curr. Drug Deliv., 2010, 7, 144–151.
   PubMedGoogle Scholar
• A. P. Chimalakonda and R. Mehvar: ‘Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: local immunosuppressive effects in liver after systemic administration to rats’, Pharm. Res., 2003, 20, 198–204.
   PubMed Web of Science ®Google Scholar
• A. Scomparin, S. Salmaso, S. Bersani, F. R. Satchi and P. Caliceti: ‘Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery’, Eur. J. Pharm. Sci., 2011, 42, 547–558.
   PubMed Web of Science ®Google Scholar
• Y. S. Peng, S. C. Lin, S. J. Huang, Y. M. Wang, Y. J. Lin, L. F. Wang and J. S. Chen: ‘Chondroitin sulfate-based anti-inflammatory macromolecular prodrugs’, Eur. J. Pharm. Sci., 2006, 29, 60–69.
   PubMed Web of Science ®Google Scholar
• B. Schlechter, A. Neumann, M. Wilchek and R. Arnon: ‘Soluble polymers as carriers of cis-platinum’, J. Control. Release, 1989, 10, 75–87.
   Web of Science ®Google Scholar
• W. C. Biddle, Y. Haruta, B. K. Seon, E. S. Henderson and E. J. Sarcione: ‘In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates’, Leuk. Res., 1989, 13, 699–707.
   PubMed Web of Science ®Google Scholar
• R. Duncan and J. Kopecek: ‘Soluble synthetic polymers as potential drug carriers’, Adv. Polym. Sci., 1984, 57, 51–101.
   Web of Science ®Google Scholar
• R. Duncan: ‘Drug-polymer conjugates: potential for improved chemotherapy’, Anti-Cancer Drugs, 1992, 3, 175–210.
   PubMed Web of Science ®Google Scholar
• G. Mocanu, A. Airinie and A. Carporv: ‘Macromolecular drug conjugates. 5. Theophylline-dextran’, J. Control. Release, 1996, 40, 1–9.
   Web of Science ®Google Scholar
• S. Pugazhendhy, P. K. Shrivastava, S. K. Sinha, K. Sushant and S. K. Shrivastava: ‘Lamotrigine–dextran conjugates-synthesis, characterization, and biological evaluation’, Med. Chem. Res., 2011, 20, 595–600.
   Web of Science ®Google Scholar
• J. S. Lee, Y. J. Jung, M. J. Doh and Y. M. Kim: ‘Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid’, Drug Dev. Ind. Pharm., 2001, 27, 331–336.
   PubMed Web of Science ®Google Scholar
• R. Axén and S. Ernback: ‘Chemical fixation of enzymes to cyanogen halide activated polysaccharide carriers’, Eur. J. Biochem., 1971, 18, 351–360.
   PubMedGoogle Scholar
• J. J. Marshall and M. L. Rabinowitz: ‘Preparation and characterization of a dextran-trypsin conjugate’, J. Biol. Chem., 1976, 251, 1081–1087.
   PubMed Web of Science ®Google Scholar
• T. Kojima, M. Hashida, S. Muranishi and H. Sezaki: ‘Mitomycin C-dextran conjugate: a novel high molecular weight pro-drug of mitomycin C’, J. Pharm. Pharmacol., 1980, 32, 30–34.
   PubMed Web of Science ®Google Scholar
• S. Dimitriu and E. Chornet: ‘Polysaccharides as support for enzyme and cell immobilization’, in ‘Polysaccharides, structural diversity and functional versatility’, (ed. S. Dimitriu), 1998, New York, Marcel Dekker.
   Google Scholar
• T. Heinze, T. Liebert, B. Heublein and S. Hornig: ‘Functional polymers based on dextran’, Adv. Polym. Sci., 2006, 205, 199–291.
   Web of Science ®Google Scholar
• V. Pozsgay: ‘Conjugation of biomolecules using Diels-Alder cycloaddition’, U. S. Patent, 6673905B2, 2004.
   Google Scholar
• S. D. Mikolajczyk, D. L. Meyer, R. Fagnani, M. S. Hagan, K. L. Law and J. J. Starling: ‘Dextran modification of a fab‘β-lactamase conjugate modulated by variable pretreatment of fab‘ with amine-blocking reagents’, Bioconj. Chem., 1996, 7, 150–158.
   PubMed Web of Science ®Google Scholar
• R. Fagnani, M. S. Hagan and R. Bartholomew: ‘Reduction of immunogenicity by covalent modification of murine and rabbit immunoglobulins with oxidized dextrans of low molecular weight’, Cancer Res., 1990, 50, 3638–3645.
   PubMed Web of Science ®Google Scholar
• J. Tu, S. Zhong and P. Li: ‘Studies on acyclovir-dextran conjugate: synthesis and pharmacokinetics’, Drug Dev. Ind. Pharm., 2004, 30, 959–965.
   PubMed Web of Science ®Google Scholar
• D. V. Arefjev, N. S. Domnina, E. A. Komarova and A. Y. Bilibin: ‘Sterically hindered phenol-dextran conjugates: synthesis and radical scavenging activity’, Eur. Polym. J., 1999, 35, 279–284.
   Web of Science ®Google Scholar
• T. Heinze, T. F. Liebert, K. S. Pfeiffer and M. A. Hussain: ‘Unconventional cellulose esters: synthesis, characterization and structure–property relationship’, Cellulose, 2003, 10, 283–296.
   Web of Science ®Google Scholar
• T. Liebert, M. A. Hussain, M. N. Tahir and T. Heinze: ‘Synthesis and characterization of cellulose α-lipoates: a novel material for adsorption onto gold’, Polym. Bull., 2006, 57, 857–863.
   Web of Science ®Google Scholar
• M. A. Hussain, D. Shahwar, M. N. Hassan, M. N. Tahir, M. S. Iqbal and M. Sher: ‘An efficient esterification of pullulan using activated carboxylic acid anhydrides with iodine’, Collect. Czech. Chem. Commun., 2010, 75, 133–143.
   Google Scholar
• M. A. Hussain, D. Shahwar, M. N. Tahir, M. Sher, M. N. Hassan and Z. Afzal: ‘An efficient acetylation of dextran using in situ activated acetic anhydride with iodine’, J. Serb. Chem. Soc., 2010, 75, 165–173.
   Web of Science ®Google Scholar
• S. Yolles, J. F. Morton and M. F. Sartori: ‘Preparation of steroid esters of hydroxypropyl cellulose’, J. Polym. Sci., 1979, 17, 4111–4113.
   Web of Science ®Google Scholar
• M. A. Hussain, T. Liebert and T. Heinze: ‘Acylation of cellulose with N,N′-carbonyldiimidazole-activated acids in the novel solvent dimethyl sulfoxide/tetrabutylammonium fluoride’, Macromol. Rapid Commun., 2004, 25, 916–920.
   Web of Science ®Google Scholar
• S. K. Shrivastava, D. K. Jain and P. Trivedi: ‘Dextrans-potential polymeric drug carriers for suprofen’, Pharmazie, 2003, 58, 804–806.
   PubMed Web of Science ®Google Scholar
• S. K. Shrivastava, D. K. Jain and P. Trivedi: ‘Dextrans-potential polymeric drug carriers for flurbiprofen’, Pharmazie, 2003, 58, 389–391.
   PubMed Web of Science ®Google Scholar
• M. A. Hussain, T. Liebert and T. Heinze: ‘First report on a new esterification method for cellulose’, Polym. News, 2004, 29, 14–17.
   Google Scholar
• L. Hovgaard and H. Brondsted: ‘Current applications of polysaccharides in colon targeting’, Crit. Rev. Ther. Drug Carrier Syst., 1996, 13, 185–223.
   PubMed Web of Science ®Google Scholar
• A. R. Jeanes: ‘Encyclopedia of polymer science and technology’, 1966, New York, Wiley-Interscience.
   Google Scholar
• A. R. Jeanes: ‘Dextran bibliography’, US Dept. Agric. Agric. Res. Ser. Peoria, 1967. [Through Chem. Abstr. 1968; 68: 22902]
   Google Scholar
• K. Akiyoshi, S. Deguchi, N. Moriguchi, S. Yamaguchi and J. Sunamoto: ‘Self-aggregates of hydrophobized polysaccharides in water: formation and characteristics of nanoparticles’, Macromolecules, 1993, 26, 3062–3068.
   Web of Science ®Google Scholar
• H. Maeda, T. Sawa and T. Konno: ‘Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS’, J. Control. Release, 2001, 74, 47–61.
   PubMed Web of Science ®Google Scholar
• Y. Kato, S. Ozawa, C. Miyamoto, Y. Maehata, A. Suzuki, T. Maeda and Y. Baba: ‘Acidic extracellular microenvironment and cancer’, Cancer Cell Int., 2013, 13, 89–96.
   PubMed Web of Science ®Google Scholar
• H. Maeda: ‘SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy’, Adv. Drug Deliv. Rev., 2001, 46, 169–185.
   PubMed Web of Science ®Google Scholar
• V. P. Torchilin: ‘Targeted pharmaceutical nanocarriers for cancer therapy and imaging’, AAPS J., 2007, 9, (2), Article 15.
   PubMed Web of Science ®Google Scholar
• D. Lu, X. Wen, J. Liang, Z. Gu, X. Zhang and Y. Fan: ‘A pH-sensitive nano drug delivery system derived from pullulan/doxorubicin conjugate’, J. Biomed. Mater. Res. B. Appl. Biomater., 2009, 89, 177–183.
   PubMed Web of Science ®Google Scholar
• H. Nogusa, T. Yano, S. Okuno, H. Hamana and K. Inoue: ‘Synthesis of carboxymethylpullulan-peptide-doxorubicin conjugates and their properties’, Chem. Pharm. Bull., 1995, 43, (11), 1931–1936.
   PubMed Web of Science ®Google Scholar
• A. Agarwal, U. Gupta, A. Asthana and N. K. Jain: ‘Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent’, Biomaterials, 2009, 30, 3588–3596.
   PubMed Web of Science ®Google Scholar
• S. Sugahara, M. Kajiki, H. Kuriyama and T. Kobayashi: ‘Complete regression of xenografted human carcinomas by a paclitaxel–carboxymethyl dextran conjugate (AZ10992)’, J. Control. Release, 2007, 117, 40–50.
   PubMed Web of Science ®Google Scholar
• Y. Chau, N. M. Dang, F. E. Tan and R. Langer: ‘Investigation of targeting mechanism of new dextran-peptide-methotrexate conjugates using biodistribution study in matrix-metalloproteinase-overexpressing tumor xenograft model’, J. Pharm. Sci., 2006, 95, 542–551.
   PubMed Web of Science ®Google Scholar
• M. Harada, H. Sakakibara, T. Yano, T. Suzuki and S. Okuno: ‘Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate’, J. Control. Release, 2000, 69, 399–412.
   PubMed Web of Science ®Google Scholar
• M. Harada, J. Murata, Y. Sakamura, H. Sakakibara, S. Okuno and T. Suzuki: ‘Carrier and dose effects on the pharmacokinetics of T-0128, a camptothecin analogue-carboxymethyl dextran conjugate, in non-tumor- and tumor-bearing rats’, J. Control. Release, 2001, 71, 71–86.
   PubMed Web of Science ®Google Scholar
• M. Hashida, A. Kato, Y. Takakura and H. Sezaki: ‘Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat’, Drug Metab. Dispos., 1984, 12, 492–499.
   PubMed Web of Science ®Google Scholar
• Y. Takakura, R. Atsumi, M. Hashida and H. Sezaki: ‘Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. II. Disposition and pharmacokinetics following intravenous and intramuscular administration’, Int. J. Pharm., 1987, 37, 145–154.
   Web of Science ®Google Scholar
• T. Nomura, A. Saikawa, S. Morita, T. Sakaeda, F. Yamashita, K. Honda, Y. Takakura and M. Hashida: ‘Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection’, J. Control. Release, 1998, 52, 239–252.
   PubMed Web of Science ®Google Scholar
• Y. Takakura, R. I. Mahato, M. Nishikawa and M. Hashida: ‘Control of pharmacokinetic profiles of drug-macromolecule conjugates’, Adv. Drug Deliv. Rev., 1996, 19, 377–399.
   Web of Science ®Google Scholar
• F. Takuya, Y. Yoshihisa, Y. Takakura, M. Hashida and H. Sezaki: ‘Alteration of biopharmaceutical properties of drugs by their conjugation with water-soluble macromolecules: uricase-dextran conjugate’, J. Control. Release, 1990, 11, (1–3), 149–156.
   Web of Science ®Google Scholar
• J. Zhong and Y. Chau: ‘Synthesis, characterization, and thermodynamic study of a polyvalent lytic peptide-polymer conjugate as novel anticancer agent’, Bioconj. Chem., 2010, 21, (11), 2055–2064.
   PubMed Web of Science ®Google Scholar
• J. Nakamura, N. Nakajima, K. Matsumura and S. H. Hyon: ‘Water-soluble taxol conjugates with dextran and targets tumor cells by folic acid immobilization’, Anticancer Res., 2010, 30, (3), 903–909.
   PubMed Web of Science ®Google Scholar
• D. Nevozhay, R. Budzynska, M. Jagiello, U. Kanska, M. S. Omar, A. Opolski, J. Wietrzyk and J. Boratynski: ‘The effect of the substitution level of some dextran-methotrexate conjugates on their antitumor activity in experimental cancer models’, Anticancer Res., 2006, 26, (3A), 2179–2186.
   PubMed Web of Science ®Google Scholar
• Y. Wang, Y. Liu, Y. Liu, W. Zhou, H. Wang, G. Wan, D. Sun, N. Zhang and Y. Wang: ‘A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma’, Int. J. Pharm., 2015, 483, 89–100.
   PubMed Web of Science ®Google Scholar
• E. Harboe, C. Larsen, M. Johansen and H. P. Olesen: ‘Macromolecular prodrugs XIV. Absorption characteristics of naproxen after oral administration of dextran T-70-naproxen ester prodrug in pigs’, Int. J. Pharm., 1989, 53, 157–165.
   Web of Science ®Google Scholar
• S. Ahmad, R. F. Tester, A. Corbett and J. Karkalas: ‘Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis’, Carbohydr. Res., 2006, 341, 2694–2701.
   PubMed Web of Science ®Google Scholar
• C. Larsen, E. Harboe, M. Johansen and H. P. Olesen: ‘Macromolecular prodrugs. XVI Colon-targeted delivery-comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract’, Pharm. Res., 1989, 6, 995–999.
   PubMed Web of Science ®Google Scholar
• C. Larsen, B. H. Jensen and H. P. Olesen: ‘Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig’, Acta Pharm. Nord., 1991, 3, 71–76.
   PubMedGoogle Scholar
• P. Kurtzhals, C. Larsen and M. Johansen: ‘Preliminary studies on the in vivo fate of FITC-dextrans and naproxen-dextran ester prodrugs administered i.v. to rabbits’, Acta Pharm. Nord., 1989, 1, 201–210.
   PubMedGoogle Scholar
• E. Harboe, M. Johansen and C. Larsen: ‘Macromolecular prodrugs VI. Coupling of naproxen to dextrans and in vivo characterization of the conjugates’, Farmaci. Sci. Ed., 1988, 16, 73–85.
   Google Scholar
• E. Harboe, C. Larsen and M. Johansen: ‘Macromolecular prodrugs X. Bioavailability of naproxen after oral administration of dextran-naproxen ester conjugates in rabbits’, Farmaci. Sci. Ed., 1988, 16, 65–72.
   Google Scholar
• S. Vyas, P. Trivedi and S. C. Chaturvedi: ‘Ketorolac-dextran conjugates: synthesis, in vitro and in vivo evaluation’, Acta Pharm., 2007, 57, 441–450.
   PubMedGoogle Scholar
• S. Vyas, P. Trivedi and S. C. Chaturvedi: ‘Dextran-etodolac conjugates: synthesis, in vitro and in vivo evaluation’, Acta Pol. Pharm. Drug Res., 2009, 66, 201–206.
   PubMed Web of Science ®Google Scholar
• Y. Lee, I. H. Kim, J. Kim, J. H. Yoon, Y. H. Shin, Y. Jung and Y. M. Kim: ‘Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy’, J. Drug Target., 2011, 19, (5), 336–343.
   PubMed Web of Science ®Google Scholar
• K. C. Chimalakonda, H. K. Agarwal, A. Kumar, K. Parang and R. Mehvar: ‘Synthesis, analysis, in vitro characterization, and in vivo disposition of a lamivudine-dextran conjugate for selective antiviral delivery to the liver’, Bioconj. Chem., 2007, 18, (6), 2097–2108.
   PubMed Web of Science ®Google Scholar
• K. Xi, Y. Tabata, K. Uno, M. Yashimoto, T. Kishida, Y. Sokawa and Y. Ikada: ‘Liver targeting of interferon through pullulan conjugation’, Pharm. Res., 1996, 13, (12), 1846–1850.
   PubMed Web of Science ®Google Scholar
• S. P. Hudson, R. Langer, G. R. Fink and D. S. Kohane: ‘Injectable in situ cross-linking hydrogels for local antifungal therapy’, Biomaterials, 2010, 31, (6), 1444–1452.
   PubMed Web of Science ®Google Scholar
• M. Fuentes, C. Mateo, R. F. Lafuente and J. M. Guisan: ‘Aldehyde–dextran–protein conjugates to immobilize amino-haptens: avoiding cross-reactions in the immunodetection’, Enzyme Microb. Tech., 2005, 36, (4), 510–513.
   Web of Science ®Google Scholar
• Y. Takakura, Y. Kaneko, T. Fujita, M. Hashida, H. Maeda and H. Sezaki: ‘Control of pharmaceutical properties of soybean trypsin inhibitor by conjugation with dextran I: synthesis and characterization’, J. Pharm. Sci., 1989, 78, (2), 117–121.
   PubMed Web of Science ®Google Scholar
• R. Pawankar, R. Takizawa, M. Goto, Y. Goto, M. Okuda, S. Yamagishi, K. Ohkubo, M. Nonaka, H. Ohtsuka and T. Yagi: ‘Effect of modified immunotherapy with an allergen–pullulan conjugate in patients with Japanese cedar pollinosis’, Allergol. Int., 2001, 50, (1), 43–55.
   Google Scholar
• A. Sjostorm, P. Bue, P. U. Malmstorm, S. Nilsson and J. Carlsson: ‘Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell lines’, Int. J. Cancer, 1997, 70, (4), 383–389.
   PubMed Web of Science ®Google Scholar
• Y. N. Pang, Y. Zhang and Z. R. Zhang: ‘Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting’, World J. Gastroenterol., 2002, 8, 913–917.
   PubMed Web of Science ®Google Scholar
• S. Kim, Y. S. Chae, K. Na, S. W. Kim and Y. H. Bae: ‘Insulinotropic activity of sulfonylurea/pullulan conjugate in rat islet microcapsule’, Biomaterials, 2003, 24, (26), 4843–4851.
   PubMed Web of Science ®Google Scholar
• Y. Kaneo, Y. Fujihara, T. Tanaka, K. Ogawa, K. Fujita and S. Iguchi: ‘Preparation and characterization of a soluble glutathione-dextran conjugate’, Int. J. Pharm., 1989, 57, (3), 263–272.
   Web of Science ®Google Scholar
• H. Yura, N. Yoshimura, T. Hamashima, K. Akamatsu, M. Nishikawa, Y. Takakura and M. Hashida: ‘Synthesis and pharmacokinetics of a novel macromolecular prodrug of Tacrolimus (FK506), FK506–dextran conjugate’, J. Control. Release, 1999, 57, (1), 87–99.
   PubMed Web of Science ®Google Scholar
• M. A. Hussain, K. Abbas, M. Sher, M. N. Tahir, W. Tremel, M. S. Iqbal, M. Amin and M. Badshah: ‘Macromolecular prodrugs of aspirin with HPMC: a nano particulate drug design, characterization, and pharmacokinetic studies’, Macromol. Res., 2011, 19, (12), 1296–1302.
   Web of Science ®Google Scholar
• C. Elvira, A. Gallardo, J. S. Roman and A. Cifuentes: ‘Covalent polymer-drug conjugates’, Molecules, 2005, 10, 114–125.
   PubMed Web of Science ®Google Scholar
• M. A. Hussain, M. Badshah, M. S. Iqbal, M. N. Tahir, W. Tremel, S. V. Bhosale, M. Sher and M. T. Haseeb: ‘HPMC-salicylate conjugates as macromolecular prodrugs: design, characterization and nano-rod formation’, J. Polym. Sci. A: Pol. Chem., 2009, 47, 4202–4208.
   Web of Science ®Google Scholar
• M. A. Hussain, B. A. Lodhi, K. Abbas, R. N. Paracha, M. R. Shah and M. A. Arsalan: ‘Novel HPC-ibuprofen conjugates: synthesis, characterization, thermal analysis and degradation kinetics’, J. Chem. Soc. Pak., 2014, 36(1), 78–84.
   Web of Science ®Google Scholar
• M. A. Hussain, R. Kausar, M. Amin and M. R. Shah: ‘Mefenamic acid conjugates based on a hydrophilic biopolymer hydroxypropylcellulose: novel prodrug design, characterization and thermal analysis’, J. Chem. Soc. Pak., 2015, 37, (1), 46–52.
   Web of Science ®Google Scholar
• A. Rasheed, U. Krishna, P. S. Reddy and A. Mishra: ‘Synthesis and characterization of novel dextran-conjugated macromolecules of aceclofenac’, Ars Pharm., 2011, 52, (1), 5–11.
   Google Scholar
• M. A. Hussain, A. Zarish, K. Abbas, M. Sher, M. N. Tahir, W. Tremel, M. Amin, A. Ghafoor and B. A. Lodhi: ‘Hydroxypropylcellulose-aceclofenac conjugates: high covalent loading design, structure characterization, nano-assemblies and thermal kinetics’, Cellulose, 2013, 20, (2), 717–725.
   Web of Science ®Google Scholar
• J. Panyam and V. Labhasetwar: ‘Biodegradable nanoparticles for drug and gene delivery to cells and tissue’, Adv. Drug Deliv. Rev., 2003, 55, 329–347.
   PubMed Web of Science ®Google Scholar
• S. V. Vinogrado, E. V. Batrakova, A. V. Kabanov: ‘Nanogels for oligonucleotide delivery to the brain’, Bioconj. Chem., 2004, 15, 50–60.
   PubMed Web of Science ®Google Scholar
• B. K. Nanjwade, H. M. Bechra, G. K. Derkar, F. V. Manvi and V. K. Nanjwade: ‘Dendrimers: emerging polymers for drug-delivery systems’, Eur. J. Pharm. Sci., 2009, 38, 185–196.
   PubMed Web of Science ®Google Scholar
• G. Gonçalves, P. Pereira and M. Gama: ‘Self-assembled hydrogel nanoparticles for drug delivery applications’, Materials, 2010, 3, 1420–1460.
   Web of Science ®Google Scholar
• S. Horing, H. Bunjes and T. Heinze: ‘Preparation and characterization of nanoparticles based on dextran-drug conjugates’, J. Colloid Interface Sci., 2009, 338, (1), 56–62.
   PubMed Web of Science ®Google Scholar
• M. A. Hussain, K. Abbas, B. A. Lodhi, M. Sher, M. Ali, M. N. Tahir, W. Tremel and S. Iqbal: ‘Fabrication, characterization, thermal stability and nanoassemblies of novel pullulan-aspirin conjugates’, Arab. J. Chem., 2015, doi:10.1016/j.arabjc.2013.06.001.
   Google Scholar
• Z. Wang, T. Y. Lee and P. C. Ho: ‘A novel dextran-oleate-cRGDfK conjugate for self-assembly of nanodrug’, Nanomed.: Nanotechnol. Biol. Med., 2012, 8, (2), 194–203.
   PubMed Web of Science ®Google Scholar
• H. Zhang, F. Gao, L. Liu, X. Li, Z. Zhou, X. Yang and Q. Zhang: ‘Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy’, Colloid Surf. B: Biointerface, 2009, 71, (1), 19–26.
   PubMed Web of Science ®Google Scholar
• A. P. Goodwin, S. M. Tabakman, K. Welsher, S. P. Sherlock, G. Prencipe and H. Dai: ‘Phospholipid-dextran with a single coupling point: a useful amphiphile for functionalization of nanomaterials’, J. Am. Chem. Soc., 2009, 131, (1), 289–296.
   PubMed Web of Science ®Google Scholar
• A. Anitha, V. G. Deepagan, V. V. D. Rani, D. Menon, S. V. Nair and R. Jayakumar: ‘Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles’, Carbohydr. Polym., 2011, 84, 1158–1164.
   Web of Science ®Google Scholar
• I. S. Kim and I. J. Oh: ‘Preparation and characterization of stearic acid-pullulan nanoparticles’, Arch. Pharm. Res., 2010, 33, (5), 761–767.
   PubMed Web of Science ®Google Scholar
• J. Li and P. Yao: ‘Self-assembly of ibuprofen and bovine serum albumin–dextran conjugates leading to effective loading of the drug’, Langmuir, 2009, 25, (11), 6385–6391.
   PubMed Web of Science ®Google Scholar
• W. Deng, J. Li, P. Yao, F. He and C. Huang: ‘Green preparation process, characterization and antitumor effects of doxorubicin-BSA-dextran nanoparticles’, Macromol. Biosci., 2010, 10, (10), 1224–1234.
   PubMed Web of Science ®Google Scholar
• J. Qi, P. Yao, F. He, C. Yu and C. Huang: ‘Nanoparticles with dextran/chitosan shell and BSA/chitosan core-doxorubicin loading and delivery’, Int. J. Pharm., 2010, 393, (1–2), 177–185.
   Web of Science ®Google Scholar
• Y. I. Jeong, K. D. Chung and K. C. Choi: ‘Doxorubicin release from self-assembled nanoparticles of deoxycholic acid-conjugated dextran’, Arch. Pharm. Res., 2011, 34, (1), 159–167.
   PubMed Web of Science ®Google Scholar
• K. Na, K. H. Lee and Y. H. Bae: ‘pH-sensitivity and pH-dependent interior structural change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugate’, J. Control. Release, 2004, 97, (3), 513–525.
   PubMed Web of Science ®Google Scholar
• Y. When-Zhi, C. Hong-Li, G. Fu-Ping, C. Min-Mao, L. Xue-Min, Z. Ming-Ming, Z. Qi-Qing, L. Ling-Rong, J. Qian, W. Yin-Song: ‘Self-aggregated nanoparticles of cholesterol-modified pullulan conjugate as a novel carrier of mitoxantronep’, Curr. Nanosci., 2010, 6, (3), 298–306.
   Web of Science ®Google Scholar
• B. Bae and K. Na: ‘Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy’, Biomaterials, 2010, 31, (24), 6325–6335.
   PubMed Web of Science ®Google Scholar
• H. Zhang, X. Li, F. Gao, L. Liu, Z. Zhou and Q. Zhang: ‘Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery’, Drug Deliv., 2010, 17, (1), 48–57.
   PubMed Web of Science ®Google Scholar
• B. L. Brannon-Peppas and J. O. Blanchette: ‘Nanoparticle and targeted systems for cancer therapy’, Adv. Drug Deliv. Rev., 2012, 64, 206–212.
   Web of Science ®Google Scholar
• M. S. Iqbal, J. Akbar, S. Saghir, A. Karim, A. Koschella, T. Heinze and M. Sher: ‘Thermal studies of plant carbohydrate polymer hydrogel’, Carbohydr. Polym., 2011, 8, 1775–1783.
   Web of Science ®Google Scholar
• H. S. Neto, F. A. P. Barros, F. M. de Sousa Carvalho and J. R. Matos: ‘Thermal analysis of prednicarbate and characterization of thermal decomposition product’, J. Therm. Anal. Calorim., 2010, 102, 277–283.
   Web of Science ®Google Scholar
• F. S. Felix, L. C. Cides da Silva, L. Angnes and J. R. Matos: ‘Thermal behavior study and decomposition kinetics of salbutamol under isothermal and non-isothermal conditions’, J. Therm. Anal. Calorim., 2009, 95, 877–880.
   Web of Science ®Google Scholar
• D. Giron: ‘Applications of thermal analysis and coupled techniques in pharmaceutical industry’, J. Therm. Anal. Calorim., 2002, 68, 335–357.
   Web of Science ®Google Scholar
• R. Rohanizadeh and N. Kokabi: ‘Heat denatured/aggregated albumin-based biomaterial: effects of preparation parameters on biodegradability and mechanical properties’, J. Mater. Sci. Mater. Med., 2009, 20, (12), 2413–2418.
   PubMed Web of Science ®Google Scholar
• M. A. Villetti, J. S. Crespo, M. S. Soldi, A. T. N. Pires, R. Borsali and V. Soldi: ‘Thermal degradation of natural polymers’, J. Therm. Anal. Calorim., 2002, 67, 295–303.
   Web of Science ®Google Scholar